Cigna Group

CINYSECIK 1739940FinancialsFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 177 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Cigna Group, Reports and events
Filed	Form	What it is	Accession number
2021-11-2906:15 ET	8-K	7.01 Regulation FD disclosure	0000950159-21-000335
2021-11-0412:09 ET	10-Q	Quarterly reportPeriod 2021-09-30	0001739940-21-000024
2021-11-0406:15 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000950159-21-000310
2021-09-2306:05 ET	8-K	5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0000950159-21-000290
2021-09-0206:15 ET	8-K	7.01 Regulation FD disclosure	0000950159-21-000283
2021-08-0512:19 ET	10-Q	Quarterly reportPeriod 2021-06-30	0001739940-21-000017
2021-08-0506:15 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000950159-21-000207
2021-07-3006:05 ET	8-K	5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits	0000950159-21-000192
2021-05-2806:15 ET	8-K	7.01 Regulation FD disclosure	0000950159-21-000176
2021-05-0710:10 ET	10-Q	Quarterly reportPeriod 2021-03-31	0001739940-21-000011
2021-05-0706:15 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000950159-21-000142
2021-05-0316:30 ET	8-K/A	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0000950159-21-000139
2021-05-0316:30 ET	8-K	5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits	0000950159-21-000138
2021-04-3006:15 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits	0001140361-21-015041
2021-03-1916:31 ET	DEF 14A	Proxy statementPeriod 2021-04-28	0001140361-21-009343
2021-03-0806:15 ET	8-K	7.01 Regulation FD disclosure	0000950159-21-000116
2021-03-0317:10 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0001140361-21-007207
2021-02-2608:03 ET	8-K	7.01 Regulation FD disclosure	0000950159-21-000111
2021-02-2512:24 ET	10-K	Annual reportPeriod 2020-12-31	0001739940-21-000007
2021-02-0406:15 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000950159-21-000014
2021-01-1216:30 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0000950159-21-000006
2020-12-3116:20 ET	8-K	7.01 Regulation FD disclosure	0000950159-20-000286
2020-12-2806:15 ET	8-K	7.01 Regulation FD disclosure	0000950159-20-000281
2020-12-1116:30 ET	8-K	5.02 Departure or appointment of officers or directors	0000950159-20-000278
2020-12-1007:35 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0000950159-20-000273
2020-11-3006:16 ET	8-K	7.01 Regulation FD disclosure	0000950159-20-000270
2020-11-0512:22 ET	10-Q	Quarterly reportPeriod 2020-09-30	0001739940-20-000021
2020-11-0506:15 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000950159-20-000238
2020-10-3016:15 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0000950159-20-000231
2020-09-0906:15 ET	8-K	7.01 Regulation FD disclosure	0000950159-20-000223
2020-08-2006:15 ET	8-K	7.01 Regulation FD disclosure	0000950159-20-000211
2020-08-0607:43 ET	10-Q	Quarterly reportPeriod 2020-06-30	0001739940-20-000017
2020-07-3006:18 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000950159-20-000161
2020-05-2606:15 ET	8-K	7.01 Regulation FD disclosure	0000950159-20-000142
2020-05-0707:19 ET	10-Q	Quarterly reportPeriod 2020-03-31	0001739940-20-000012
2020-04-3006:15 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000950159-20-000110
2020-04-2416:17 ET	8-K	5.07 Shareholder vote results	0000950159-20-000099
2020-04-2416:15 ET	8-K/A	5.02 Departure or appointment of officers or directors	0000950159-20-000098
2020-04-0316:15 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits	0000950159-20-000089
2020-03-1616:17 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0001140361-20-005865
2020-03-1317:02 ET	DEF 14A	Proxy statementPeriod 2020-04-22	0001140361-20-005769
2020-03-0506:07 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001140361-20-004888
2020-02-2715:25 ET	10-K	Annual reportPeriod 2019-12-31	0001739940-20-000006
2020-02-2706:01 ET	8-K	5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0000950159-20-000057
2020-02-1906:05 ET	8-K	7.01 Regulation FD disclosure	0001140361-20-003579
2020-02-0606:15 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000950159-20-000034
2020-01-1306:15 ET	8-K	7.01 Regulation FD disclosure	0000950159-20-000008
2019-12-3006:30 ET	8-K	7.01 Regulation FD disclosure	0000950159-19-000321
2019-12-2716:15 ET	8-K	8.01 Other events	0000950159-19-000319
2019-12-1116:15 ET	8-K	5.05 Item not in the standard list; 8.01 Other events	0000950159-19-000295

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 13:13 ET. Listed shows no prices and gives no investment advice.